Ditchcarbon
  • Contact
  1. Organizations
  2. GlaxoSmithKline Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
CA
updated 2 months ago

GlaxoSmithKline Inc.

Company website

GlaxoSmithKline Inc. (GSK), a leading global healthcare company, is headquartered in California and operates extensively across North America, Europe, and Asia. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has established itself as a key player in the pharmaceutical and biotechnology sectors, focusing on research and development in vaccines, pharmaceuticals, and consumer healthcare products. GSK's core offerings include innovative medicines for respiratory, HIV, and oncology treatments, as well as a robust portfolio of vaccines and consumer health products. The company is renowned for its commitment to scientific excellence and patient-centric solutions, which have positioned it among the top pharmaceutical firms worldwide. With a strong emphasis on sustainability and access to healthcare, GSK continues to achieve significant milestones in improving global health outcomes.

DitchCarbon Score

How does GlaxoSmithKline Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

100

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

GlaxoSmithKline Inc.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

GlaxoSmithKline Inc.'s reported carbon emissions

Inherited from GSK plc

As of the latest reporting, GlaxoSmithKline Inc. does not provide specific carbon emissions data, indicating a lack of available figures for the most recent year. The company is a current subsidiary of GSK plc, which may influence its climate commitments and emissions reporting. GSK plc has established various climate initiatives that GlaxoSmithKline Inc. adheres to, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives aim to enhance transparency and accountability in emissions reduction efforts. While specific reduction targets for GlaxoSmithKline Inc. are not detailed, the overarching commitments from GSK plc suggest a focus on significant reductions in greenhouse gas emissions across all scopes. The company is involved in initiatives such as RE100, which promotes the transition to 100% renewable electricity, and the Climate Pledge, which underscores its commitment to climate action. In summary, while GlaxoSmithKline Inc. does not currently report specific emissions data, it is aligned with the broader climate strategies and commitments of its parent company, GSK plc, which are designed to address climate change and reduce carbon footprints effectively.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201420152016201720182019202020212022202320242025
Scope 1
851,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000,000
Scope 2
745,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
00,000,000
00,000,000,000
Scope 3
16,093,000,000
00,000,000,000
00,000,000,000
00,000,000,000
00,000,000,000
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
-
0,000,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. GlaxoSmithKline Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for GlaxoSmithKline Inc. is in CA, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

GlaxoSmithKline Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Astrazeneca Canada Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Pharmascience Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Valeant Canada Ltd.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Merck Canada Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Teva Canada Limited

CA
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Bayer Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 27 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251023.17
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy